MedPacto (235980) has 1 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩116M ($80K) in reported transaction value. The earliest filing StockDrifts holds for MedPacto is dated 2025-03-05; the most recent is 2025-03-06. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +60.11%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2025-03-06 | BUY | PROGRAM | 우정원 Woojeongwon | president | 15.0K | ₩3,635 | +60.1% | ₩55M ($38K) |
| 2025-03-06 | BUY | PROGRAM | 김성진 Seongjin Kim | CEO | 31.9K | ₩3,635 | +60.1% | ₩116M ($80K) |
| 2025-03-06 | BUY | PROGRAM | 이지훈 Jihoon Lee | Managing Director | 7.0K | ₩3,635 | +60.1% | ₩25M ($18K) |
| 2025-03-05 | BUY | PROGRAM | 양경민 Kyungmin Yang | Managing Director | 10.0K | ₩3,405 | +70.9% | ₩34M ($24K) |
| 2025-03-05 | BUY | PROGRAM | 장민후 Jang Min-hoo | Managing Director | 10.5K | ₩3,405 | +70.9% | ₩36M ($25K) |
| 2025-03-05 | BUY | PROGRAM | 허민규 Heo Min-gyu | Managing Director | 10.0K | ₩3,405 | +70.9% | ₩34M ($24K) |
| 2025-03-05 | BUY | PROGRAM | 우정원 Woojeongwon | president | 15.0K | ₩3,405 | +70.9% | ₩51M ($35K) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for MedPacto. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.